Parkland Memorial Hospital
Dallas, Texas, 75235, United States
NCT Number: NCT00689754
Upper gastrointestinal tract hemorrhage (UGIH) remains a major cause of morbidity and mortality . Nasogastric aspiration (NGA) is routinely performed in patients with UGIH to obtain important clinical data and make therapeutic decisions. But routine use of NGA remains controversial with studies reporting its usefulness and its redundant clinical information. Early esophagogastroduodenoscopy (EGD) is recommended by most gastrointestinal societies to allow for risk stratification and to perform endoscopic treatments. The results of the NGA may assist to differentiate between high-risk versus low-risk lesions. Our hypothesis is that presence of NGA can identify lesions that require endoscopic treatment and provides important clinical information to guide the treating physician. In addition, we hypothesized that the results of the NGA influence the clinical decision of the treating physician regarding the prediction of the need for endoscopic therapy. This observational randomized cross-sectional study will enroll consecutive patients with presumed UGIH and randomized them to NGA and no NGA recording its results. All patients will receive an EGD and its results will also be recorded. Subsequently, we will evaluate if the NGA is important in identifying endoscopically significant lesions. The information gained will help guide clinicians evaluating patient with UGIH.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Dallas, Texas, 75235, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
standard nasogastric tube placement, aspiration and lavage up to 1L of normal saline
Time frame: 24h
Time frame: 24h
Time frame: 24h
Time frame: 24h
Time frame: 24h
University of Texas Southwestern Medical Center
Other
The Role of Routine Placement of Nasogastric Tube in Patients With Suspected Upper Gastrointestinal Hemorrhage
Acronym: NG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05816473
Digestive System Diseases, Gastrointestinal Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT03499808
Amorphous, Eosinophilic, and Acellular Deposit, Amyloidosis
Anchorage, Alaska, United States
View Trial DetailsNCT02514304
Cardiovascular Diseases, Digestive System Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT06269302
Anticoagulants and Bleeding Disorders, Cardiovascular Diseases
Samsun, İlkadım, Turkey (Türkiye)
View Trial Details